Better Therapeutics to Participate in Two Upcoming Investor Conferences
February 09 2023 - 4:01PM
Business Wire
Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital
therapeutics (PDT) company developing a clinically validated,
software-based novel form of cognitive behavioral therapy to
address the root causes of cardiometabolic diseases, today
announced that the Company will participate in two upcoming
investor conferences in February and March 2023.
- BTIG MedTech, Digital Health, Life Science & Diagnostic
Tools Conference being held in Snowbird, UT on February 14 and 15,
2023.
- Cowen 43rd Annual Health Care Conference being held in Boston,
MA on March 6, 2023. Better Therapeutics is scheduled to present at
11:10 a.m. ET / 8:10 a.m. PT.
Better Therapeutics management will be available for one-on-one
meetings during the conferences. The webcast and replay of the
Cowen conference presentation will be available on the
Presentations and Events page of the Better Therapeutics website at
www.bettertx.com for approximately 30 days after the event.
About Better Therapeutics
Better Therapeutics is a prescription digital therapeutics
company developing a novel form of cognitive behavioral therapy to
address the root causes of cardiometabolic diseases. The company
has developed a proprietary platform for the development of
FDA-regulated, software-based solutions for type 2 diabetes, heart
disease and other conditions. The CBT delivered by Better
Therapeutics’ PDT is designed to enable changes in neural pathways
of the brain so lasting changes in behavior become possible.
Addressing the underlying causes of these diseases has the
potential to dramatically improve patient health while lowering
healthcare costs. Better Therapeutics’ clinically validated mobile
applications, if authorized for marketing, are intended to be
prescribed by physicians and reimbursed like traditional
medicines.
For more information visit: bettertx.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230209005718/en/
Investor Relations: Mark Heinen IR@bettertx.com
Media: Ryan McKenna at Real Chemistry
rmckenna@realchemistry.com
Better Therapeutics (NASDAQ:BTTX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Better Therapeutics (NASDAQ:BTTX)
Historical Stock Chart
From Sep 2023 to Sep 2024